These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38304725)

  • 1. Antimicrobial susceptibility in
    Birhanu M; Abegaz WE; Schröder D; Mihret A; Abebe T; Jacobsson S; Tasew G; Addis T; Abdeta A; Alem Y; Desalegn Z; Ademe M; Teka B; Yohannes M; Yigeremus M; Golparian D; Gebre-Selassie S; Unemo M
    JAC Antimicrob Resist; 2024 Feb; 6(1):dlae002. PubMed ID: 38304725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial resistance and molecular epidemiological typing of Neisseria gonorrhoeae isolates from Kyrgyzstan in Central Asia, 2012 and 2017.
    Karymbaeva S; Boiko I; Jacobsson S; Mamaeva G; Ibraeva A; Usupova D; Golparian D; Unemo M
    BMC Infect Dis; 2021 Jun; 21(1):559. PubMed ID: 34118893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial susceptibility in
    Latif AS; Gwanzura L; Machiha A; Ndowa F; Tarupiwa A; Gudza-Mugabe M; Shukusho FD; Chakanyuka Musanhu C; Wi T; Unemo M
    Sex Transm Infect; 2018 Feb; 94(1):62-66. PubMed ID: 28476914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial resistance in Neisseria gonorrhoeae isolates and gonorrhoea treatment in the Republic of Belarus, Eastern Europe, 2009-2019.
    Aniskevich A; Shimanskaya I; Boiko I; Golubovskaya T; Golparian D; Stanislavova I; Jacobsson S; Adaskevich A; Unemo M
    BMC Infect Dis; 2021 Jun; 21(1):520. PubMed ID: 34078300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates and treatment of gonorrhoea patients in Ternopil and Dnipropetrovsk regions of Ukraine, 2013-2018.
    Boiko I; Golparian D; Krynytska I; Bezkorovaina H; Frankenberg A; Onuchyna M; Jacobsson S; Unemo M
    APMIS; 2019 Jul; 127(7):503-509. PubMed ID: 30903707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First nationwide antimicrobial susceptibility surveillance for Neisseria gonorrhoeae in Brazil, 2015-16.
    Bazzo ML; Golfetto L; Gaspar PC; Pires AF; Ramos MC; Franchini M; Ferreira WA; Unemo M; Benzaken AS;
    J Antimicrob Chemother; 2018 Jul; 73(7):1854-1861. PubMed ID: 29635367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017-18: a retrospective observational study.
    Unemo M; Lahra MM; Escher M; Eremin S; Cole MJ; Galarza P; Ndowa F; Martin I; Dillon JR; Galas M; Ramon-Pardo P; Weinstock H; Wi T
    Lancet Microbe; 2021 Nov; 2(11):e627-e636. PubMed ID: 35544082
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Kittiyaowamarn R; Girdthep N; Cherdtrakulkiat T; Sangprasert P; Tongtoyai J; Weston E; Borisov A; Dunne EF; Chinhiran K; Woodring J; Ngarmjiratam N; Masciotra S; Frankson R; Sirivongrangson P; Unemo M; Wi T
    JAC Antimicrob Resist; 2023 Dec; 5(6):dlad139. PubMed ID: 38115859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National surveillance of
    Machado HM; Martins JM; Schörner MA; Gaspar PC; Bigolin A; Ramos MC; Ferreira WA; Pereira GFM; Miranda AE; Unemo M; Bazzo ML;
    JAC Antimicrob Resist; 2022 Aug; 4(4):dlac076. PubMed ID: 35795244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016.
    Day MJ; Spiteri G; Jacobsson S; Woodford N; Amato-Gauci AJ; Cole MJ; Unemo M;
    BMC Infect Dis; 2018 Dec; 18(1):609. PubMed ID: 30509194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Russian gonococcal antimicrobial susceptibility programme (RU-GASP)--resistance in Neisseria gonorrhoeae during 2009-2012 and NG-MAST genotypes in 2011 and 2012.
    Kubanova A; Kubanov A; Frigo N; Solomka V; Semina V; Vorobyev D; Khairullin R; Unemo M
    BMC Infect Dis; 2014 Jun; 14():342. PubMed ID: 24947981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial resistance and Neisseria gonorrhoeae multiantigen sequence typing (NG-MAST) genotypes in N. gonorrhoeae during 2012-2014 in Karachi, Pakistan.
    Jabeen K; Bhawan Mal P; Khan E; Chandio S; Jacobsson S; Unemo M
    BMC Infect Dis; 2016 Jul; 16():353. PubMed ID: 27449234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic epidemiology and antimicrobial resistance determinants of Neisseria gonorrhoeae isolates from Ukraine, 2013-2018.
    Boiko I; Golparian D; Jacobsson S; Krynytska I; Frankenberg A; Shevchenko T; Unemo M
    APMIS; 2020 Jul; 128(7):465-475. PubMed ID: 32441045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant increase in azithromycin "resistance" and susceptibility to ceftriaxone and cefixime in Neisseria gonorrhoeae isolates in 26 European countries, 2019.
    Day MJ; Jacobsson S; Spiteri G; Kulishev C; Sajedi N; Woodford N; Blumel B; van der Werf MJ; Amato-Gauci AJ; Unemo M; Cole MJ;
    BMC Infect Dis; 2022 Jun; 22(1):524. PubMed ID: 35672671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between antimicrobial susceptibility/resistance of Neisseria gonorrhoeae isolates in European Union/European Economic Area and patients' gender, sexual orientation and anatomical site of infection, 2009-2016.
    Jacobsson S; Cole MJ; Spiteri G; Day M; Unemo M;
    BMC Infect Dis; 2021 Mar; 21(1):273. PubMed ID: 33736608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility/resistance and NG-MAST characterisation of Neisseria gonorrhoeae in Belarus, Eastern Europe, 2010-2013.
    Lebedzeu F; Golparian D; Titov L; Pankratava N; Glazkova S; Shimanskaya I; Charniakova N; Lukyanau A; Domeika M; Unemo M
    BMC Infect Dis; 2015 Jan; 15():29. PubMed ID: 25637258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Europe-wide expansion and eradication of multidrug-resistant Neisseria gonorrhoeae lineages: a genomic surveillance study.
    Sánchez-Busó L; Cole MJ; Spiteri G; Day M; Jacobsson S; Golparian D; Sajedi N; Yeats CA; Abudahab K; Underwood A; Bluemel B; Aanensen DM; Unemo M;
    Lancet Microbe; 2022 Jun; 3(6):e452-e463. PubMed ID: 35659907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First characterisation of antimicrobial susceptibility and resistance of Neisseria gonorrhoeae isolates in Qatar, 2017-2020.
    Al-Maslamani M; Elmagboul EBI; Puthiyottil A; Chemaitelly H; Varghese MK; Al Romaihi HE; Al-Thani MH; Al Khal A; Unemo M; Abu-Raddad LJ
    PLoS One; 2022; 17(3):e0264737. PubMed ID: 35235608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of a Gonococcal Antimicrobial Surveillance Programme, in Accordance With World Health Organization Standards, in Côte d'Ivoire, Western Africa, 2014-2017.
    Yéo A; Kouamé-Blavo B; Kouamé CE; Ouattara A; Yao AC; Gbedé BD; Bazan F; Faye-Ketté H; Dosso M; Wi T; Unemo M
    Sex Transm Dis; 2019 Mar; 46(3):179-184. PubMed ID: 30461598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic surveillance and antimicrobial resistance determinants in Neisseria gonorrhoeae isolates from Uganda, Malawi and South Africa, 2015-20.
    Kakooza F; Golparian D; Matoga M; Maseko V; Lamorde M; Krysiak R; Manabe YC; Chen JS; Kularatne R; Jacobsson S; Godreuil S; Hoffman I; Bercot B; Wi T; Unemo M
    J Antimicrob Chemother; 2023 Aug; 78(8):1982-1991. PubMed ID: 37352017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.